Company Overview and News
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
It's a great feeling to receive a lot of dividends throughout the year, then on the following April 15, realizing that you don't have to pay tax on any of that income. There are many stocks, which are
Concerned about taxes? Looking for income? Check out tax free income stocks. There are many stocks, which are primarily closed end funds, which pay dividends that are tax free. This tax free income is
Somehow I missed this but that doesn’t mean anything, I miss a lot of things. So if you’re up to speed on the government providing reinsurance for municipal bonds then skip this post.If no
All closed end (CEF) fund types advanced the week ending 4/9/09 in an undulating, holiday-shortened week. Average price appreciation of 13 CEF fund types was 1.6%, while the unweighted average
Summary: All closed end (CEF) fund types advanced the week ending 4/9/09 in an undulating, holiday-shortened week. Average price appreciation of 13 CEF fund types was 1.6%, while the unweighte
In the fourth quarter of 2008, the municipal bond market collapsed along with the rest of the credit markets. Lately there has been a small revival. Still, depressed bond prices and wide spread credit
Are you concerned about the possibility of higher taxes on dividends? You might want to take a look at tax free income stocks. There is a group of stocks out there, technically closed end funds, which
Short-Term National Municipal Bond ETFs (click on symbol for data and articles) iShares S&P Short Term AMT-Free National Municipal Bond Fund (NYSEARCA:SUB) Market Vectors-Lehman Brothers AMT-Free
These are closed-end funds [with a few exceptions] that pay dividends that are free of federal income taxes, and they all trade on either the New York Stock Exchange or American Stock Exchange. The di
Time for the quarterly update of the list of stocks, including exchange-listed closed end funds [CEFs], that pay their dividends monthly. Many income investors are looking for monthly dividend payment
During the last few months, I have provided articles on the stocks, including exchange-listed closed end funds [CEFs], that pay their dividends monthly. Many income investors are looking for monthly p
I have added over 25 additional stocks to my list of stocks [including closed end funds] that pay dividends monthly. The list now totals over 125 different monthly dividend payers. Monthly dividend st
Many stock market investors are looking for high dividend stocks that provide them with a monthly retirement income. Other investors are looking for monthly dividend stocks for their retirement plans
21h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
21h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...